Innovative drugs and CRO concepts continue to strengthen, with multiple stocks such as Shanghai Model Organisms hitting the daily limit.

Innovative drugs and CRO concepts extended their gains in intraday trading. Shanghai Model Organisms hit the 20% limit up, while Novoprotein and ACROBiosystems rose over 10%, both hitting record highs. Earlier, CanSino Biologics, TNM Biopharma, Kangchen Pharmaceutical, and Aosaikang Pharmaceutical hit the limit up, with JenKem Technology, CSPC Innovation, Jinbo Bio, and PharmaBlock Sciences among the top gainers.